EODData

MEMBERSHIP REGISTER LOG IN

LSE, IMM: Immupharma PLC

16 Oct 2025
LAST:

9.900

CHANGE:
 0.00		OPEN:
9.920		HIGH:
10.950		ASK:
0.000		VOLUME:
2.37M
CHG(%):
0.00		PREV:
9.900		LOW:
9.900		BID:
1.400		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Oct 259.92010.9509.9009.9002.37M
15 Oct 2510.65011.3009.8209.9002.29M
14 Oct 2510.15011.4509.32510.4007.06M
13 Oct 2511.50012.00010.15010.4007.68M
10 Oct 2511.75012.66511.05011.1002.34M
09 Oct 2511.70013.00011.05012.0004.55M
08 Oct 2511.80012.50010.55011.7002.66M
07 Oct 2510.75012.30010.25011.3004.52M
06 Oct 2512.00013.9509.52011.10010.14M
03 Oct 2512.05013.40011.65011.9005.03M

COMPANY PROFILE

Name:Immupharma PLC
About:ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company's lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140, which is in Phase II clinical trial for the treatment of chronic inflammatory demyelinating polyneuropathy, a rare acquired autoimmune disorder of peripheral nerve; and P140 that covers other indications acute and chronic asthma, gout, irritable bowel disease, and periodontitis. Its pre-clinical products include BioAMB, a peptide-based drug of Amphotericin-B formulations for the treatment of serious and life-threatening fungal infections, such as aspergillosis; and BioCin, a vancomycin based treatment for anti-infection. It has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of 1P40 platform; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:One Bartholomew Close, London, United Kingdom, EC1A 7BL
Website:https://www.immupharma.co.uk
ISIN:GB0033711010
LEI:213800VZKGHXC7VUS895

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:10.344.4%
MA10:10.9710.8%
MA20:11.1512.6%
MA50:7.6928.7%
MA100:4.9799.0%
MA200:4.18136.6%
STO14:19.44 
RSI14:47.45
WPR14:-73.63
MTM14:1.11
ROC14:0.13 
ATR:2.36 
Week High:13.0031.3%
Week Low:9.336.2%
Month High:18.9090.9%
Month Low:8.28136.6%
Year High:19.4096.0%
Year Low:0.851,064.7%

RECENT DIVIDENDS

Date Amount
14 Dec 2021$3.00